Site-directed mutagenesis of human IL-29 and antineoplastic activity of the recombinant human IL-29 variant / 生物工程学报
Chinese Journal of Biotechnology
; (12): 702-710, 2015.
Article
Dans Zh
| WPRIM
| ID: wpr-240607
Responsable en Bibliothèque :
WPRO
ABSTRACT
To explore the anti-tumor proliferation activity of human interleukin-29 (hIL-29) variant and based on bioinformatics analyzed data of hIL-29, a mutant gene hIL-29(mut33,35) was amplified by site-directed mutagenesis and megaprimer PCR. The hIL-29(mut33,35) was inserted into an eukaryotic expression plasmid pPIC9K and successfully expressed in Pichia pastoris GS115. A recombinant variant protein (rhIL-29(mut33,35)) was purified from the ferment supernatant of the engineering GS115. To observe the antineoplastic activity of the variant rhIL-29(mut33,35), a CCK-8 reagent was used to detect the anti-proliferation effect. Results show that it has strong anti-proliferation effect when acted on liver cancer cell BEL7402, colon cancer cell HCT8 and gastric cancer cell SGC7901. The inhibition ratios of the three tumor cells were (30.99 ± 1.58)%, (22.47 ± 1.37)% and (32.05 ± 2.02)%, respectively. In high dose group, the anti-proliferation effect of the rhIL-29(mut33,35) was stronger than that of wild type rhIL-29 (P < 0.01). This indicates the variant rhIL-29(mut33,35) has potential development value for medicine.
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Anatomopathologie
/
Pharmacologie
/
Pichia
/
Plasmides
/
Protéines recombinantes
/
Réaction de polymérisation en chaîne
/
Mutagenèse dirigée
/
Interleukines
/
Carcinome hépatocellulaire
/
Lignée cellulaire tumorale
Limites du sujet:
Humans
langue:
Zh
Texte intégral:
Chinese Journal of Biotechnology
Année:
2015
Type:
Article